Search

everythinglearnresearchcommunity

for

Search:↓

Treating vitiligo with stem cells and melanocytes from hair, along with UVB light, works better than without the light.

Melanocytes from human fetal hair follicles were successfully cultured, showing potential for hair disease research and clinical use.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Betamethasone activates and increases the growth of certain skin cells from hair follicles.

Amelanotic melanocytes from hair follicles are immature and likely don't transfer melanosomes to keratinocytes.

Melanin granules can be expelled by exocytosis.

1,25-dihydroxyvitamin D3 helps melanocyte precursors from hair follicles grow and produce melanin, aiding vitiligo treatment understanding.

Transplantation is effective for stable leucoderma but not for progressive, widespread vitiligo vulgaris.

A human serum-enriched medium effectively supports melanocyte growth and activity without using animal-derived supplements.

Clear documentation and shared best practices are essential for improving research consistency in pigment cells.

The new assay can track and measure melanosome transfer between skin cells, confirming filopodia's role in this process.

Melanocyte transplantation can safely restore skin color, especially in stable vitiligo, but must be chosen carefully based on the disease phase.

Low oxygen levels improve the function of hair and skin cells when they are in direct contact.

The created skin model with melanoblasts improves the study of skin color and offers an alternative to animal testing.

Melanocyte progenitor cells are found in human fat tissue and can become mature melanocytes, which may help treat skin issues.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Mouse epidermal neural crest stem cells can become various cell types and are easily obtained from hair follicles.

Mouse Epidermal Neural Crest Stem Cells can become various cell types.

In vitro methods for testing cosmeceuticals need improvement for better human relevance and reliability.

Surgical therapies for vitiligo vary in effectiveness, with combination therapy and medical tattooing recommended for better results.

Hair follicle-derived sheets can effectively treat vitiligo by repigmenting skin.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Surgical methods like suction blister grafting and split-thickness skin grafting are highly successful for vitiligo repigmentation, but choosing the right patients is crucial for success.

Hair follicle stem cells help maintain skin health and could improve skin replacement therapies.

New treatments for vitiligo show promise but still face challenges, especially for hands and feet.

Dermal papilla cells are key for hair growth and color, influencing hair type and size, and their interaction with stem cells could help treat hair loss and color disorders.

Surgical repigmentation can permanently restore color to white hair in vitiligo patients.

Gray hair regained color after thyroid hormone treatment.

Regenerative medicine is effective and safe for treating vitiligo.

α-MSH and cyclic AMP boost melanin production, while cyclic GMP and melatonin reduce it.